Kimberly-Clark (KMB) delivered mixed results for 2021 and Q1 2022, mixing some organic growth and margin pressure. See why I rate KMB stock a hold.
→ Google Переводчик
Global menstrual health and hygiene programs benefitted 8.7 million people in 2021 DALLAS, May 27, 2022 /PRNewswire/ -- Globally, more than 800 million women and girls are stigmatized, excluded and discriminated against simply because they menstruate. An additional 500 million lack access…
→ Google Переводчик
New Jersey, NJ -- ( SBWIRE ) -- 05/25/2022 -- The Tissue Paper Market has witnessed continuous growth in past few years and is projected to grow at good pace during the forecast period of 2022-2027. The exploration provides a 360° view and insights, highlighting major outcomes of Tissue Paper industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability. Additionally, the study helps venture or emerging players in understanding the businesses to make well-informed decisions. Some of the major and emerging players within the market are Kimberly-Clark, Essity (from SCA), Procter & Gamble, Georgia-Pacific, Sofidel, Empresas CMPC, Hengan International, APP (Sinar Mas Group), WEPA, Metsa Group, Kruger, Cascades, C & S & ICT Group. If you are part of Tissue Paper market, then benchmark how you are perceived in comparison to your competitors; Get an accurate view of your business in Tissue Paper Marketplace with latest released study by HTF MI Get free access to sample report @: https://www.
→ Google Переводчик
Highest-yielding dividend stocks like these typically offer a safe haven during market turbulence. Altria ( MO ): Tobacco products are more resilient to recessions and better insulated from inflationary pressures. Cardinal Health ( CAH ): Saw a 17% increase in its pharmaceutical segment revenue. Chevron ( CVX ): Offers a secure way to profit from rising oil and gas prices. Kimberly-Clark ( KMB ): Reported a record 10% increase in organic sales despite a 6% increase in prices. Lumen Technologies ( LUMN ): Generates an impressive 8.4% dividend yield with a 48% payout ratio. Magellan Midstream Partners ( MMP ): Offers a whopping 8.2% dividend yield. Medical Properties Trust ( MPW ): Deserves readers’ attention with a 6.3% yield after the 4% quarterly dividend hike. Source: Shutterstock In times of increased volatility, highest-yielding dividend stocks mean stability and consistent passive income for long-term portfolios. Multiple studies have highlighted that over time, dividend shares outpace stocks that don’t pay dividends by a wide margin.
→ Google Переводчик
SAO PAULO — Kimberly-Clark Corp is planning to sell its tissue paper assets in Brazil and Latin America, newspaper Valor Economico reported on Friday, saying the company is in talks with JPMorgan to reassess its business in the region. Though a price tag has yet to be decided, market estimates suggest Kimberly-Clark’s assets are valued […]
→ Google Переводчик
Kimberly-Clark upped its guidance for 2022, but don''t count your chickens before they''ve hatched. A key competitor is closely watching prices.
→ Google Переводчик
Kimberly-Clark Corp is planning to sell its tissue paper assets in Brazil and Latin America, per a report from Brazilian financial paper Valor Economico.
→ Google Переводчик
Those looking for the best retirement stocks should consider companies tied to powerful market trajectories. American Water Works ( AWK ): A water utility investment, AWK is one of the retirement stocks that sells itself due to addressing critical needs. Dominion Energy ( D ): With retirement stocks to buy for any age, you really can’t go wrong with utility investments like Dominion. Iron Mountain ( IRM ): Comprehensive storage solutions makes IRM relevant amid a spike in data breaches and infrastructural compromises. Whirlpool ( WHR ): A company off the beaten path, WHR could enjoy downwind benefits due to the surge in home purchases. Hormel Foods ( HRL ): No matter what market cycle we’re in, food will always be critical, making HRL a no-brainer among retirement stocks to buy. Starbucks ( SBUX ): Given that Starbucks caters to the beverage preferences of Generation Z, you can grow with SBUX in your portfolio. Kimberly Clark ( KMB ): A popular manufacturer of important household goods, KMB is one of the most reliable retirement stocks to buy.
→ Google Переводчик
JACKSONVILLE, Fla., March 03, 2022 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency” or the “Company”) (NASDAQ:REG) today announced that Lisa Palmer, President and Chief Executive Officer, is scheduled to make a presentation at the 2022 Citi Global Property CEO Conference (the “Conference”) on Tuesday, March 8, 2022, at 10:30 am ET. To access the Company’s live presentation, use the webcast registration link below.
→ Google Переводчик
JACKSONVILLE, Fla., March 03, 2022 (GLOBE NEWSWIRE) -- Regency Centers Corporation ("Regency" or the "Company") (NASDAQ: REG ) today announced that Lisa Palmer, President and Chief Executive Officer, is scheduled to make a presentation at the 2022 Citi Global Property CEO Conference (the "Conference") on Tuesday, March 8, 2022, at 10:30 am ET. To access the Company''s live presentation, use the webcast registration link below. Regency … Full story available on Benzinga.com
→ Google Переводчик
Regency Centers Corporation with ticker code (REG) now have 17 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 92 and 73 with a mean TP of 80.12. Now with the previous closing price of 66.72 this indicates there is a potential upside of 20.1%. The 50 day MA is 72.22 and the 200 moving average now moves to 68.86. The market capitalisation for the company is $11,447m. Company Website: https://www.regencycenters.com [stock_market_widget type="chart" template="basic" color="green" assets=REG" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $13,746m based on the market concensus. Regency Centers is the preeminent national owner, operator, and developer of shopping centers located in affluent and densely populated trade areas. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers.
→ Google Переводчик
Within the last quarter, Regency Centers (NASDAQ: REG ) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 1 0 1 0 0 3M Ago 1 1 1 0 0 According to 6 analyst offering 12-month price targets in the last 3 months, Regency Centers has an average price target of $81.83 with a high of $92.00 and a low of $75.00. Below is a summary of how these 6 analysts rated Regency Centers over the past 3 months. The greater Full story available on Benzinga.com
→ Google Переводчик
Related Stocks: REG ,
→ Google Переводчик
JACKSONVILLE, Fla., June 24, 2021 (GLOBE NEWSWIRE) -- Regency Centers Corporation (The Company) (NASDAQ: REG) will announce its Second Quarter 2021 earnings results on Thursday, August 5, 2021, after the market closes. The Companys earnings release and supplemental information package will be posted on the Investor Relations section of the Companys website investors.regencycenters.com . The Company will host an earnings conference call on Friday, August 6, 2021, at 11:00 a.m. ET.
→ Google Переводчик
Within the last quarter, Regency Centers (NASDAQ: REG ) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 0 0 Somewhat Bullish 0 2 0 0 Indifferent 1 2 0 0 Somewhat Bearish 0 0 0 0 Bearish 0 0 0 0 In the last 3 months, 6 analysts have offered 12-month price targets for Regency Centers. The company has an average price target of $62.75 with a high of $67.00 and a low of $47.50. This current average represents a 13.47% increase from the previous average price target of $55.3. How Are Full story available on Benzinga.com
→ Google Переводчик
Related Stocks: REG ,
→ Google Переводчик
JACKSONVILLE, Fla., June 07, 2021 (GLOBE NEWSWIRE) -- Today, Regency Centers Corporation (Regency or the Company) (NASDAQ: REG) announced the release of its annual Corporate Responsibility Report. The report illustrates Regencys continued commitment to corporate responsibility, as well as key environmental, social, and governance initiatives and achievements. The report can be found on Regencys Corporate Responsibility website .
→ Google Переводчик
Regency Centers Corporation with ticker code (REG) now have 14 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 72 and 47.5 calculating the average target price we see 65.18. Given that the stocks previous close was at 66.81 this is indicating there is a potential downside of -2.4%. The 50 day MA is 63.39 and the 200 day MA is 54.19. The market capitalisation for the company is $11,175m. Visit the company website at: /> [stock_market_widget type="chart" symbol="REG" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Regency Centers is the preeminent national owner, operator, and developer of shopping centers located in affluent and densely populated trade areas. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers.
→ Google Переводчик
JACKSONVILLE, Fla., June 02, 2021 (GLOBE NEWSWIRE) -- Regency Centers Corporation ("Regency" or the "Company") (NASDAQ: REG ) today announced that Lisa Palmer, President and Chief Executive Officer, is scheduled to make a presentation at Nareit's REITweek: 2021 Virtual Investor Conference (the "Conference") on Tuesday, June 8, 2021, at 3:00 pm ET. To access the Company's live presentation, attendees are required to register for the Conference, using the registration link below. Registration for the Conference is complimentary. Regency Centers Virtual … Full story available on Benzinga.com
→ Google Переводчик
JACKSONVILLE, Fla., June 02, 2021 (GLOBE NEWSWIRE) -- Regency Centers Corporation ("Regency" or the "Company") (NASDAQ: REG ) today announced that Lisa Palmer, President and Chief Executive Officer, is scheduled to make a presentation at Nareit''s REITweek: 2021 Virtual Investor Conference (the "Conference") on Tuesday, June 8, 2021, at 3:00 pm ET. To access the Company''s live presentation, attendees are required to register for the Conference, using the registration link below. Registration for the Conference is complimentary. Regency Centers Virtual Full story available on Benzinga.com
→ Google Переводчик
JACKSONVILLE, Fla., June 02, 2021 (GLOBE NEWSWIRE) -- Regency Centers Corporation (Regency or the Company) (NASDAQ:REG) today announced that Lisa Palmer, President and Chief Executive Officer, is scheduled to make a presentation at Nareits REITweek: 2021 Virtual Investor Conference (the Conference) on Tuesday, June 8, 2021, at 3:00 pm ET. To access the Companys live presentation, attendees are required to register for the Conference, using the registration link below. Registration for the Conference is complimentary.
→ Google Переводчик
EAST PALO ALTO, CALIF. Regency Centers has completed the sale of Gateway 101, a shopping center located at 1771 E. Bayshore Road in East Palo Alto. A private foreign investor acquired the property for $53.2 million. Built in 2000 and renovated in 2017, Gateway 101 features 92,110 square feet of retail space. At the [] The post Regency Centers Sells 92,110 SF Gateway 101 Retail Center in East Palo Alto, California appeared first on REBusinessOnline .
→ Google Переводчик
JACKSONVILLE, Fla., May 19, 2021 (GLOBE NEWSWIRE) -- Regency Centers Corporation (Regency or the Company) announced today that its Board of Directors (the Board) has appointed James (Jim) H. Simmons III as its newest member. Mr. Simmons is currently the CEO and Founding Partner of Asland Capital Partners, a private equity firm focusing on acquiring, repositioning, and operating best-in-class multifamily, mixed-use and retail assets in revitalizing sub-markets. He has spent much of his career managing, originating and structuring real estate transactions across the public and private sectors. With the addition of Mr. Simmons as an independent director, Regency has expanded the size of the Board to twelve directors.
→ Google Переводчик
Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Regency Centers Co. (NASDAQ:REG) by 20.3% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 328,588 shares of the companys stock after acquiring an additional 55,529 shares during the quarter. Zurcher Kantonalbank Zurich []
→ Google Переводчик
Handelsbanken Fonder AB raised its stake in shares of Regency Centers Co. (NASDAQ:REG) by 57.9% during the 1st quarter, HoldingsChannel reports. The firm owned 34,900 shares of the companys stock after purchasing an additional 12,800 shares during the quarter. Handelsbanken Fonder ABs holdings in Regency Centers were worth $1,979,000 as of its most recent filing []
→ Google Переводчик
Regency Centers Co. (NASDAQ:REG) COO James D. Thompson sold 7,500 shares of the businesss stock in a transaction that occurred on Friday, May 7th. The stock was sold at an average price of $66.00, for a total value of $495,000.00. Following the transaction, the chief operating officer now directly owns 26,584 shares in the company, []
→ Google Переводчик
Daiwa Securities Group Inc. increased its position in shares of Regency Centers Co. (NASDAQ:REG) by 3,442.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,609,176 shares of the companys stock after acquiring an additional 1,563,750 shares during the []
→ Google Переводчик
BMO Capital Stick to Their Hold Rating for Regency Centers
→ Google Переводчик
JACKSONVILLE, Fla., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Regency Centers Corporation (The “Company”) (NASDAQ: REG) will announce its Fourth Quarter 2020…
→ Google Переводчик
VANCOUVER, British Columbia, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Regulus Resources Inc. ("Regulus" or the "Company", TSX-V: REG, OTCQX: RGLSF…
→ Google Переводчик
Here's a name we didn't expect to see emerge in Washington H Soul Pattinson and Co Ltd's bid to take out ASX-listed aged care operator Regis Healthcare.
→ Google Переводчик
Washington H Soul Pattinson and Co Ltd has made a $1.85 a share cash and/or scrip bid for ASX-listed aged care operator Regis Healthcare.
→ Google Переводчик
Merrill Lynch Stick to Their Buy Rating for Regency Centers
→ Google Переводчик
NEW YORK, Sept. 3, 2020 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Regulus Resources Inc. (TSX-V: REG; OTCQX: RGLSF), a Canadian mineral exploration company with operations in Peru, has…
→ Google Переводчик
After much anticipation, popular international discount grocer, Lidl, has opened its doors at Regency's Brighten Park shopping center in Atlanta. The store occupies 24,625 SF of space between… | July 8, 2020
→ Google Переводчик
The underlying trend currently is to the downside for stocks in Regency Centers Corporation. The trend should continue over the coming trading sessions and thereby open the door for lower price… | June 18, 2020
→ Google Переводчик
Regency Centers (REG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
→ Google Переводчик
Significant exposure to essential businesses at its centers drives operations at Regency's (REG) properties and boosts April and May rent collections.
→ Google Переводчик
Regency Centers' (REG) focus on necessity businesses has enabled its properties to operate for the entirety of the pandemic. Yet, troubles for non-essential tenants may impact their ability to pay rent.
→ Google Переводчик
Regency Centers (REG) intends to use funds raised from senior notes offering to bolster the company's liquidity and reduce outstanding balances under its line of credit.
→ Google Переводчик
Regency Centers' (REG) same-property NOI in Q1 reflects known bankruptcy move-outs and a higher uncollectible lease income due to the COVID-19 pandemic.
→ Google Переводчик
Regency Centers (REG) delivered FFO and revenue surprises of 0.00% and -1.55%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
→ Google Переводчик
Regency Centers (REG) withdraws 2020 guidance, and updates on liquidity and financial position amid coronavirus pandemic-led crisis.
→ Google Переводчик
Regency Centers (REG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
→ Google Переводчик
Regency Centers (REG) witnesses rise in revenues in the fourth quarter of 2019, driven by an increase in lease income.
→ Google Переводчик
Regency Centers (REG) delivered FFO and revenue surprises of 2.04% and -1.33%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
→ Google Переводчик
Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) shares were rebounding Tuesday as investors digested French pharma giant and collaboration partner Sanofi SA's (NASDAQ: SNY ) potential liquidation of its Regeneron stake — and the restructuring of a collaboration agreement between the two. Hints At Regeneron Stake Sale At Sanofi's Capital Markets Day, the company announced a slew of measures intended to drive innovation and growth. Apart from prioritizing key growth drivers — Dupixent and vaccines — and accelerating an R&D focus on six potentially transformative medicines, Sanofi said it would improve operating efficiencies to fund growth. While discussing its capital allocation policy, Sanofi said that, apart from cash generated from its businesses, it has the wherewithal to raise capital through asset disposals and monetizing its stake in Regeneron after the lockup period expires in December 2020. See Also: 5 Stocks Moving On ASH Presentations The Sanofi-Regeneron Collaboration Sanofi and Regeneron entered a global collaboration agreement in November 2007 to develop fully human therapeutics antibodies using the latter's VelociSuite technologies.
→ Google Переводчик
The Royal Commission report looms. Are Japara Healthcare Ltd (ASX:JHC), Regis Healthcare Ltd (ASX:REG) and Estia Health Ltd (ASX:EHE) now dirt cheap?
→ Google Переводчик
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Regency Centers (REG) have what it takes? Let's find out.
→ Google Переводчик
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Regency Centers (REG) have what it takes? Let's find out.
→ Google Переводчик
Regency Centers' (REG) high-quality and diversified portfolio, both tenant and geography wise, impress Moody's.
→ Google Переводчик
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Sept. 9.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) ( reacted to positive Nuplazid data) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) Scpharmaceuticals Inc (NASDAQ: SCPH ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Pfenex Inc (NYSE: PFNX ) Down In The Dumps (Biotech stocks that hit 52-week lows on Sept. 9.) Advaxis, Inc. (NASDAQ: ADXS ) (reacted to third-quarter results) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Endologix, Inc. (NASDAQ: ELGX ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Illumina, Inc. (NASDAQ: ILMN ) Neurotrope Inc (NASDAQ: NTRP ) ( Alzheimer's disease drug did not meet the primary endpoint) Obalon Therapeutics Inc (NASDAQ: OBLN ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Retrophin Inc (NASDAQ: RTRX ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Surface Oncology Inc (NASDAQ: SURF ) Trinity Biotech plc (NASDAQ: TRIB ) Transenterix Inc (NYSE: TRXC ) See also: Biotech Stock On The Radar: Ardelyx Gears Up For FDA Decision Day Stocks In Focus Translate Bio Discontinues Development Of mRNA Therapy Translate Bio Inc (NASDAQ: TBIO ) said in a clinical pipeline update that it has decided to discontinue the development of MRT5201, a liver-targeted treatment for ornithine transcarbamylase, or OTC, deficiency.
→ Google Переводчик
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 27) Castle Biosciences Inc (NASDAQ: CSTL ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 27) Abeona Therapeutics Inc (NASDAQ: ABEO ) Advaxis, Inc. (NASDAQ: ADXS ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Alder Biopharmaceuticals Inc (NASDAQ: ALDR ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alimera Sciences Inc (NASDAQ: ALIM ) AnaptysBio Inc (NASDAQ: ANAB ) ASLAN PHARMACEU/ADR (NASDAQ: ASLN ) Assembly Biosciences Inc (NASDAQ: ASMB ) Cancer Genetics Inc (NASDAQ: CGIX ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Clearside Biomedical Inc (NASDAQ: CLSD ) Crinetics Pharmaceuticals Inc (NASDAQ: CRNX ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced that its current cash position will be sufficient to complete enrollment in all three patient groups of its two ongoing Phase 2 trials for its lead compound VAL-083, which is likely to occur by the fourth quarter of 2020) ICU Medical, Incorporated (NASDAQ: ICUI ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) Mallinckrodt PLC (NYSE: MNK )(reacted to an unfavorable ruling on a patent infringement lawsuit regarding its inhaled nitric oxide product) Neuralstem, Inc. (NASDAQ: CUR ) Novus Therapeutics Inc (NASDAQ: NVUS ) Obalon Therapeutics Inc (NASDAQ: OBLN ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Regenxbio Inc (NASDAQ: RGNX ) Revance Therapeutics Inc (NASDAQ: RVNC )(announced an amended agreement with Mylan NV (NASDAQ: MYL ), …
→ Google Переводчик
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 26) DURECT Corporation (NASDAQ: DRRX ) Stoke Therapeutics Inc (NASDAQ: STOK ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 26) Advaxis, Inc. (NASDAQ: ADXS ) Arbutus Biopharma Corp (NASDAQ: ABUS ) ASLAN PHARMACEU/ADR (NASDAQ: ASLN ) Avanos Medical Inc (NYSE: AVNS ) Cancer Genetics Inc (NASDAQ: CGIX ) Clearside Biomedical Inc (NASDAQ: CLSD ) Elanco Animal Health Inc (NYSE: ELAN )(Bank of America downgraded the shares to Neutral) Neurometrix Inc (NASDAQ: NURO ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Tocagen Inc (NASDAQ: TOCA ) Unity Biotechnology Inc (NASDAQ: UBX ) Zafgen Inc (NASDAQ: ZFGN ) Stocks In Focus Nuvectra To Explore Strategic Options Nuvectra Corp (NASDAQ: NVTR ) announced its decision to explore strategic alternatives to …
→ Google Переводчик
Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) has received ample support from multiple catalysts this week. On Tuesday, the company announced FDA approval for its prefilled Eylea syringe. The good news continued Wednesday with a positive clinical readout. What Happened Regeneron said positive top-line results from a pivotal Phase 3 trial that is evaluating evinacumab in patients with homozygous familial hypercholesterolemia, or HoFH - a severe inherited form of high cholesterol. Evinacumab, which has a Breakthrough Therapy designation from the FDA, is … Full story available on Benzinga.com
→ Google Переводчик
- ← сюда
- 1
- 2
- туда →